Brind.

Tempus AI's selling activity was reversed following the dismissal of a critical report by TD Cowen.

1 report, 0 independent Updated Jul 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

TD Cowen Tempus

Keep exploring

The entities involved

TD Cowen
American investment bank
- Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
- TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36
Tempus
biotechnology company based in Chicago, Illinois
- Tempus is scheduled to participate in a conference in New York City on September 4, 2025.Sun 01:41
- Tempus AI, led by Eric Lefkofsky, is acquiring Paige to enhance its digital pathology datasets.Sat 00:42

Coverage

Newest first; wire copies grouped

Jul 6Unknown outlet